Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TapERA etanercept dose reduction in rheumatoid arthritis
2012-004631-22Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Dec 2012
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of etanercept in rheumatoid arthritis (RA) (2 arms), sponsored by UZ Leuven. Started Dec 2012; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2012-004631-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004631-22.